🗣 Et en attendant le programme complet de FOCUS 2024 meets Canada, retrouvez les orateurs et participants de l'édition 2023 qui vous parlent de #focusmeeting
Jb Beauval Pignot Géraldine Ploussard Guillaume Pouessel Damien MathieuRoumiguié Roubaud Guilhem Paul Sargos

Reassuring data: very low risk of grade inflation/overtreatment induced by MRI-targeting. Congrats Michael and thanks to all co-authors for this collaborative work Romain Diamand Gaelle Fiard Thierry Roumeguere sciencedirect.com/science/articl…

Great honor to receive IMPACT Award European Urology with Marcin Miszczyk 🇵🇱🇵🇱 🇵🇱. Congrats to the entire team Shahrokh F. Shariat Ploussard Guillaume Quoc-Dien Trinh, MD, MBA Thomas Zilli Piet Ost Roderick van den Bergh Juan Gómez Rivas Giorgio Gandaglia Benjamin Pradere Ekaterina Laukhtina Takafumi Yanagisawa

Congrats to our Feb IMPACT Award winners Marcin Miszczyk & Pawel Rajwa! Their manuscript 'Efficacy of metastasis-directed therapy in PCa' was the most influential work featured in our Feb 2024 issue!

Full Article:
buff.ly/4bzxGgU

Spotlight:
buff.ly/3ToeUCd

Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsies: Results of PERFECT trial (CCAFU-PR1) ⁦Morgan Roupret⁩ ⁦Eric Barret⁩ ⁦Gaelle Fiard⁩ ⁦Jb Beauval⁩ ⁦Salin Ambroise⁩ ⁦European Urology Oncology⁩ ⁦Association Française d'Urologie - AFU⁩ sciencedirect.com/science/articl…

Autre membre du comité organisateur @FOCUS_meeting

Pouessel Damien, oncologue médical à l'IUCT Oncopole – Institut Claudius Régaud #Toulouse

Focus 2024 meets Canada : 10 et 11/10/2024 #Toulouse

Jb Beauval Pignot Géraldine Ploussard Guillaume MathieuRoumiguié Roubaud Guilhem Paul Sargos

🔥 The added-value of side-specific systematic bx in patients diagnosed by #MRI -targeted bx European Urology Oncology

🇪🇺 Huge congratulations to the remarkable European team and my fellow researchers for their relentless efforts!

Institut Jules Bordet Instituut Société Belge d'Urologie European Association of Urology (EAU)

linkinghub.elsevier.com/retrieve/pii/S…

Take 5 minutes and participate to our online survey on PCa screening and management in BPH patients candidates for enucleation
-How do you screen patients?
-How do you manage incidental PCa?

Ploussard Guillaume
Benjamin Pradere
Cosimo De Nunzio
Vincent Ⓜ️israi
Jean-Nicolas Cornu
docs.google.com/forms/d/e/1FAI…

Nous vous souhaitons une année pleine d’innovations et de nouveautés scientifiques ! Et vous remercions de votre confiance.
RDV les 10 et 11 octobre pour #FOCUS2024meetsCanada !
Jb Beauval Pignot Géraldine Ploussard Guillaume Pouessel Damien MathieuRoumiguié Roubaud Guilhem Paul Sargos
#urology #oncology

Check our study on the prediction of EPE for selecting men for nerve sparing (full/incremental/none) on Prostate Cancer and Prostatic Diseases as part of the Emerging Leaders series
nature.com/collections/fc…

pubmed.ncbi.nlm.nih.gov/38182804/

Special thanks to friend and mentor Ploussard Guillaume

Listening to 'December 2023 – Eur Urol Oncology highlights' at buzzsprout.com/2220728/142769… European Urology Oncology European Association of Urology (EAU) Ashish M. Kamat, MD, MBBS Riccardo Campi Cathy Elena Castro Alicia Morgans, MD, MPH Ploussard Guillaume Jeremy Teoh Laurence Albiges Declan Murphy

⁦Alberto Martini⁩ on stage and back to Toulouse for ⁦@FOCUS_meeting⁩. Great talk on intermediate endpoint in prostate cancer

See you tonight... And tomorrow for Focus, 5th edition 🇬🇧🇫🇷

Alberto Bossi Laurence Albiges Eric Barret Karim Bensalah Pierre Blanchard, MD Prof Ananya💙 Helissey carole Nick James Jonathan Khalifa Prof Param Mariappan Arnaud Méjean, MD, PhD Vedang Murthy Piet Ost Tom Powles Morgan Roupret Thomas Zilli Marc-Olivier Timsit, MD, PhD 🎗️

Surgery with or Without Darolutamide in High-risk and/or Locally Advanced Prostate Cancer: The SUGAR Phase 2 Trial:
✅MRI-based definition of high risk
✅ADT-sparing
✅novel exploratory endpoint (non-curable PFS)
⁦⁦Morgan Roupret⁩ ⁦Association Française d'Urologie - AFU⁩
sciencedirect.com/science/articl…

TP vs TR in csPCa Detection. No definitive proof of superiority of TP MRI-TB over TR approach, advantage for anterior/apex location but no large RCT. Looking forward to #PERFECT trial results. ⁦Morgan Roupret⁩ ⁦European Urology Oncology⁩ sciencedirect.com/science/articl…

Really pleased to share the final program

➡️ Focus meets UK, Toulouse.
October 12-13th
☀️ President : Prof Ananya💙 Morgan Roupret

🌟🌟🌟🌟🌟🌟🌟🌟🌟🌟🌟
. @FOCUS_meeting Ploussard Guillaume Jb Beauval Pignot Géraldine Pouessel Damien Roubaud Guilhem MathieuRoumiguié

Journée d’observation/formation prostatectomie robot à Toulouse. Merci à ⁦Ploussard Guillaume⁩ pour son accueil, ses conseils et à ⁦Intuitive⁩ pour l’orga!

Thank you Ploussard Guillaume for the opportunity of joining the UROSUD team. It was a great pleasure to learn from Jb Beauval Christophe ALMERAS Salin Ambroise Benjamin Pradere Dr. Tollon, Dr. Loison Marine Lesourd Thank you all for your mentorship!

Thank you Ploussard Guillaume for this great opportunity. Thank you Dr Tollon, Dr Loison, Jb Beauval , Christophe ALMERAS , Salin Ambroise , Benjamin Pradere, Marine Lesourd for all your selfless guidance, motivation and trust! 3/n

Thanks to the amazing OR and anesthesia teams for their patience and support. I also want to thank Ramsay Santé for supporting this program. And finally I want to thank my friends and co-fellows Alae Touzani and Bogdan and wish the best of luck to Claudia Kesch and Giorgio. 4/4